Cargando…

Developing Body-Components-Based Theranostic Nanoparticles for Targeting Ovarian Cancer

Ovarian cancer mortality is the highest among gynecologic malignancies. Hence, the major challenges are early diagnosis and efficient targeted therapy. Herein, we devised model theranostic nanoparticles (NPs) for combined diagnostics and delivery of chemotherapeutics, targeted to ovarian cancer cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edelman, Ravit, Assaraf, Yehuda G., Slavkin, Anton, Dolev, Tamar, Shahar, Tal, Livney, Yoav D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572588/ https://www.ncbi.nlm.nih.gov/pubmed/31060303 http://dx.doi.org/10.3390/pharmaceutics11050216

Ejemplares similares

Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy
por: Edelman, Ravit, et al.
Publicado: (2017)

Targeted Nanoparticles Harboring Jasmine-Oil-Entrapped Paclitaxel for Elimination of Lung Cancer Cells
por: Engelberg, Shira, et al.
Publicado: (2021)

Selective Targeting and Eradication of Various Human Non-Small Cell Lung Cancer Cell Lines Using Self-Assembled Aptamer-Decorated Nanoparticles
por: Barak, Daniel, et al.
Publicado: (2022)

Albumin and Hyaluronic Acid-Coated Superparamagnetic Iron Oxide Nanoparticles Loaded with Paclitaxel for Biomedical Applications
por: Vismara, Elena, et al.
Publicado: (2017)

Novel Selectively Targeted Multifunctional Nanostructured Lipid Carriers for Prostate Cancer Treatment
por: Cohen, Lital, et al.
Publicado: (2021)

Selective eradication of human non-small cell lung cancer cells using aptamer-decorated nanoparticles harboring a cytotoxic drug cargo
por: Engelberg, Shira, et al.
Publicado: (2019)

Cancer cell-selective, clathrin-mediated endocytosis of aptamer decorated nanoparticles
por: Engelberg, Shira, et al.
Publicado: (2018)

β-casein nanovehicles for oral delivery of chemotherapeutic drug combinations overcoming P-glycoprotein-mediated multidrug resistance in human gastric cancer cells
por: Bar-Zeev, Maya, et al.
Publicado: (2016)

Ovarian Cancer Targeted Theranostics
por: Nimmagadda, Sridhar, et al.
Publicado: (2020)

Cyclodextrin nanoparticles in targeted cancer theranostics
por: Bose, Roshnee, et al.
Publicado: (2023)

Aptamer Nanomaterials for Ovarian Cancer Target Theranostics
por: Zhao, Jing, et al.
Publicado: (2022)

Targeted Theranostic Nanoparticles for Brain Tumor Treatment
por: Mendes, Maria, et al.
Publicado: (2018)

Plant-Based Seafood Analogs
por: Kazir, Meital, et al.
Publicado: (2021)

Targeted Drug Delivery and Image-Guided Therapy of Heterogeneous Ovarian Cancer Using HER2-Targeted Theranostic Nanoparticles
por: Satpathy, Minati, et al.
Publicado: (2019)

MRI-traceable theranostic nanoparticles for targeted cancer treatment
por: Anani, Tareq, et al.
Publicado: (2021)

Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment
por: Marshall, Suphalak Khamruang, et al.
Publicado: (2022)

The JmjN domain as a dimerization interface and a targeted inhibitor of KDM4 demethylase activity
por: Levin, May, et al.
Publicado: (2018)

Magnetic Nanoparticle-Based Theranostics
por: Xie, Jin, et al.
Publicado: (2012)

Theranostic Upconversion Nanoparticles (I)
por: Chen, Guanying, et al.
Publicado: (2013)

Theranostic Upconversion Nanoparticles (II)
por: Han, Gang, et al.
Publicado: (2013)

Magnetic Nanoparticles in Cancer Theranostics
por: Gobbo, Oliviero L., et al.
Publicado: (2015)

Nanoparticle theranostics in cardiovascular inflammation
por: MacRitchie, Neil, et al.
Publicado: (2021)

Theranostic nanoparticles for the management of thrombosis
por: Russell, Peije, et al.
Publicado: (2022)

Gold Nanoparticles in Cancer Theranostics
por: Gao, Qinyue, et al.
Publicado: (2021)

Single-Component Bismuth Nanoparticles as a Theranostic Agent for Multimodal Imaging-Guided Glioma Therapy
por: Lu, Shu-Ting, et al.
Publicado: (2019)

A PSMA-targeted theranostic approach is unlikely to be efficient in serous ovarian cancers
por: Aide, Nicolas, et al.
Publicado: (2021)

Solid Tumor-Targeting Theranostic Polymer Nanoparticle in Nuclear Medicinal Fields
por: Makino, Akira, et al.
Publicado: (2014)

Targeted Theranostic Approach for Glioma Using Dendrimer-Based Curcumin Nanoparticle
por: Gamage, NH, et al.
Publicado: (2016)

Chitosan Nanoparticles for Therapy and Theranostics of Hepatocellular Carcinoma (HCC) and Liver-Targeting
por: Bonferoni, Maria Cristina, et al.
Publicado: (2020)

Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma
por: Vaughan, Hannah J., et al.
Publicado: (2022)

Multifunctional Nanoparticles as High-Efficient Targeted Hypericin System for Theranostic Melanoma
por: de Morais, Flávia Amanda Pedroso, et al.
Publicado: (2022)

Corrole Nanoparticles for Chemotherapy of Castration-Resistant Prostate Cancer and as Sonodynamic Agents for Pancreatic Cancer Treatment
por: Soll, Matan, et al.
Publicado: (2022)

Mitochondria-targeting theranostics
por: Kang, Han Chang
Publicado: (2018)

Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases
por: Wu, Yuao, et al.
Publicado: (2021)

Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics
por: Rabaan, Ali A., et al.
Publicado: (2022)

Lipoprotein-Inspired Nanoparticles for Cancer Theranostics
por: Ng, Kenneth K., et al.
Publicado: (2011)

Radiolabeled theranostics: magnetic and gold nanoparticles
por: Same, Saeideh, et al.
Publicado: (2016)

Theranostic applications of nanoparticles in neurodegenerative disorders
por: Ramanathan, Sahana, et al.
Publicado: (2018)

Theranostics Applications of Nanoparticles in Cancer Immunotherapy
por: Liu, Yihai, et al.
Publicado: (2018)

Magnetic nanoparticles in theranostics of malignant melanoma
por: Shevtsov, Maxim, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bqdg86qvudvmfkqkn739mppo8q